Krisztián Homicskó - Publications, H-index & Citations

Krisztián Homicskó

swiss cancer center leman

34H指数

197论文数

1.0W被引数

收录论文 47

发表时间

Familial Pancreatic Cancer Associated with a Shared BRIP1 Variant: Implications for Homologous Recombination Deficiency and Targeted Therapy 家族性胰腺癌与共享BRIP1变异相关：同源重组缺陷和靶向治疗的启示

Genes

IF2.8

2026-09-29

OAAI

Nils Degrauwe; Giovanni Dei Tos; Mounir Trimech; Krisztian Homicsko; Antonia Digklia

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors 塞格图单抗阿穆纳鲁金的安全性与药代动力学、药效学及抗肿瘤活性：一项针对晚期和/或转移性实体瘤患者的I期研究

ESMO Open

IF8.3

2026-05-13

OAAI

U. Lassen; E.M.J. van Brummelen; I. Melero; E. Angevin; H. Joensuu; N.H. Segal; M. Mau-Sørensen; N. Steeghs; M.E. Rodríguez-Ruiz; K. Homicsko; J. Tabernero; M. Cañamero; D. Dejardin; C. Habigt; E. Rossmann; E. Guarin; G. Babitzki; H.E.S. Baumann; A.P. Silva; C. Adessi

Resolving sensitivity, specificity and signal contamination in Xenium spatial transcriptomics 解析Xenium空间转录组学中的敏感性、特异性和信号污染

Nature Methods

IF32.1

2026-04-30

OAAI

Mariia Bilous; Daria Buszta; Jonathan Bac; Senbai Kang; Yixing Dong; Stephanie Tissot; Sylvie Andre; Marina Alexandre Gaveta; Christel Voize; Solange Peters; Krisztian Homicsko; Raphael Gottardo

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)对瑞士临床癌症研究小组（SAKK）开展的I期和I/II期研究者发起的临床试验的回顾性分析

ESMO Open

IF8.3

2025-10-29

OAAI

K.-L. Koster; I. Colombo; S. Hayoz; K. Eckhardt; A. Rojas Mora; D. Hess; C. Britschgi; S. Haefliger; M. Imbimbo; F. Bertoni; K. Homicsko; R. von Moos; C. Sessa; M. Joerger; A. Stathis

Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization

FRONTIERS IN ONCOLOGY

IF3.3

2025-04-03

OAAI

Ferraro, Daniela A.; Bisig, Bettina; Rotzinger, David C.; Pareja, Fresia; Missiaglia, Edoardo; Voutsadakis, Ioannis; Homicsko, Krisztian; Digklia, Antonia

TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Boni, V.; Antras, J. Fuentes; Garralda, E.; Saavedra, O.; Colombo, I.; Stathis, A.; Homicsko, K.; Brana, I.; Costanzo, S.; Gruber, D.; Cesano, A.; Fluckiger-Mangual, S.

Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study INCB123667（一种选择性CDK2抑制剂）在晚期实体瘤患者(pts)中的安全性与耐受性：一项I期研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Simonelli, M.; Lorusso, D.; Homicsko, K.; Seguy, F.; Kinder, M.; Liu, Q.; Croft, E.; Kitano, S.

Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids

NPJ PRECISION ONCOLOGY

IF8

2024-08-14

OAAI

Dutta, Devanjali; Lorenzo-Martin, L. Francisco; Rivest, Francois; Broguiere, Nicolas; Tillard, Lucie; Ragusa, Simone; Brandenberg, Nathalie; Hohnel, Sylke; Saugy, Damien; Rusakiewicz, Sylvie; Homicsko, Krisztian; Coukos, George; Lutolf, Matthias P.

Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexity

NATURE BIOTECHNOLOGY

IF41.7

2024-07-02

PREAI

Lorenzo-Martin, L. Francisco; Broguiere, Nicolas; Langer, Jakob; Tillard, Lucie; Nikolaev, Mikhail; Coukos, George; Homicsko, Krisztian; Lutolf, Matthias P.

Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion Analysis

ADVANCED SCIENCE

IF14.1

2024-06-24

OAAI

Liu, Yen-Cheng; Ansaryan, Saeid; Tan, Jiayi; Broguiere, Nicolas; Lorenzo-Martin, Luis Francisco; Homicsko, Krisztian; Coukos, George; Lutolf, Matthias P.; Altug, Hatice

B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma

ANNALS OF ONCOLOGY

IF65.4

2024-04-01

OAAI

Gavrielatou, N.; Fortis, E.; Spathis, A.; Anastasiou, M.; Economopoulou, P.; Foukas, G. R. P.; Lelegiannis, I. M.; Rusakiewicz, S.; Vathiotis, I.; Aung, T. N.; Tissot, S.; Kastrinou, A.; Kotsantis, I.; Vagia, E. M.; Panayiotides, I.; Rimm, D. L.; Coukos, G.; Homicsko, K.; Foukas, P.; Psyrri, A.

Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma 对肿瘤浸润淋巴细胞过继治疗的反应与黑色素瘤中预先存在的CD8 T髓样细胞网络有关

SCIENCE IMMUNOLOGY

IF16.3

2024-02-02

OAAI

Barras, David; Ghisoni, Eleonora; Chiffelle, Johanna; Orcurto, Angela; Dagher, Julien; Fahr, Noemie; Benedetti, Fabrizio; Crespo, Isaac; Grimm, Alizee J.; Morotti, Matteo; Zimmermann, Stefan; Duran, Rafael; Imbimbo, Martina; de Olza, Maria Ochoa; Navarro, Blanca; Homicsko, Krisztian; Bobisse, Sara; Labes, Danny; Tsourti, Zoe; Andriakopoulou, Charitini; Herrera, Fernanda; Petremand, Remy; Dummer, Reinhard; Berthod, Gregoire; Kraemer, Anne I.; Huber, Florian; Thevenet, Jonathan; Bassani-Sternberg, Michal; Schaefer, Niklaus; Prior, John O.; Matter, Maurice; Aedo, Veronica; Dromain, Clarisse; Corria-Osorio, Jesus; Tissot, Stephanie; Kandalaft, Lana E.; Gottardo, Raphael; Pittet, Mikael; Sempoux, Christine; Michielin, Olivier; Dafni, Urania; Trueb, Lionel; Harari, Alexandre; Laniti, Denarda Dangaj; Coukos, George

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma PD-1-expressing巨噬细胞和CD8 T细胞是晚期间皮瘤PD-1抑制临床获益的独立预测因子

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2023-10-25

OAAI

Homicsko, Krisztian; Zygoura, Panagiota; Norkin, Maxim; Tissot, Stephanie; Shakarishvili, Nicholas; Popat, Sanjay; Curioni-Fontecedro, Alessandra; O'Brien, Mary; Pope, Anthony; Shah, Riyaz; Fisher, Patricia; Spicer, James; Roy, Amy; Gilligan, David; Rusakiewicz, Sylvie; Fortis, Ekaterina; Marti, Nesa; Kammler, Roswitha; Finn, Stephen P.; Coukos, Georges; Dafni, Urania; Peters, Solange; Stahel, Rolf A.

Endothelial cell heterogeneity defined by single-cell spatial transcriptomic analysis of breast cancers

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Homicsko, K.; Zaman, K.; Stravodimou, A.

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient

CANCER BIOLOGY & THERAPY

IF4.6

2023-03-26

OAAI

Anchisi, Sandro; Wolfer, Anita; Bisig, Bettina; Missiglia, Edoardo; Tiab, Amine; Kamel, Ehab Mohamed; Michielin, Olivier; Coukos, George; Homicsko, Krisztian

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor- reactive CD8+T cells and reprogramming macrophages

IMMUNITY

IF26.3

2023-01-01

OAAI

Tichet, Melanie; Wullschleger, Stephan; Chryplewicz, Agnieszka; Fournier, Nadine; Marcone, Rachel; Kauzlaric, Annamaria; Homicsko, Krisztian; Deak, Laura Codarri; Umana, Pablo; Klein, Christian; Hanahan, Douglas

First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer 首次交流177Lutetium-PSMA联合前列腺癌外免疫治疗的疗效

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-10-26

OAAI

Digklia, Antonia; Boughdad, Sarah; Homicsko, Krisztian; Dromain, Clarisse; Trimech, Mounir; Dolcan, Ana; Peters, Solange; Prior, John; Schaefer, Niklaus

Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian Cancer

CLINICAL CANCER RESEARCH

IF10.2

2022-02-17

OAAI

Digklia, Antonia; Coukos, George; Homicsko, Krisztian

Turning tumors from cold to inflamed to improve immunotherapy response 将肿瘤从寒冷转变为发炎，以改善免疫治疗反应

CANCER TREATMENT REVIEWS

IF10.5

2021-12-01

PREAI

Gerard, C. L.; Delyon, J.; Wicky, A.; Homicsko, K.; Cuendet, Michel A.; Michielin, O.

Original Research Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

EUROPEAN JOURNAL OF CANCER

IF7.1

2021-05-01

103

OAAI

Ghisoni, E.; Wicky, A.; Bouchaab, H.; Imbimbo, M.; Delyon, J.; Moura, B. Gautron; Gerard, C. L.; Latifyan, S.; Ozdemir, B. C.; Caikovski, M.; Pradervand, S.; Tavazzi, E.; Gatta, R.; Marandino, L.; Valabrega, G.; Aglietta, M.; Obeid, M.; Homicsko, K.; Alfonso, N. N. Mederos; Zimmermann, S.; Coukos, G.; Peters, S.; Cuendet, M. A.; Di Maio, M.; Michielin, O.

研究方向